The World Health Organization characterized COVID-19 as a pandemic in March 2020, the second pandemic of the twenty-first century. Expanding virus populations, such as that of SARS-CoV-2, accumulate a number of narrowly shared polymorphisms, imposing a confounding effect on traditional clustering methods. In this context, approaches that reduce the complexity of the sequence space occupied by the SARS-CoV-2 population are necessary for robust clustering. Here, we propose subdividing the global SARS-CoV-2 population into six well-defined subtypes and 10 poorly represented genotypes named tentative subtypes by focusing on the widely shared polymorphisms in nonstructural (nsp3, nsp4, nsp6, nsp12, nsp13 and nsp14) cistrons and structural (spike and nucleocapsid) and accessory (ORF8) genes. The six subtypes and the additional genotypes showed amino acid replacements that might have phenotypic implications. Notably, three mutations (one of them in the Spike protein) were responsible for the geographical segregation of subtypes. We hypothesize that the virus subtypes detected in this study are records of the early stages of SARS-CoV-2 diversification that were randomly sampled to compose the virus populations around the world. The genetic structure determined for the SARS-CoV-2 population provides substantial guidelines for maximizing the effectiveness of trials for testing candidate vaccines or drugs.
16The World Health Organization characterized the COVID-19 as a pandemic in March 2020, the second 17 pandemic of the 21 st century. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a 18 positive-stranded RNA betacoronavirus of the family Coronaviridae. Expanding virus populations, as 19 that of SARS-CoV-2, accumulate a number of narrowly shared polymorphisms imposing a 20 confounding effect on traditional clustering methods. In this context, approaches that reduce the 21 complexity of the sequence space occupied by the SARS-CoV-2 population are necessary for a robust 22 clustering. Here, we proposed the subdivision of the global SARS-CoV-2 population into sixteen well-23 defined subtypes by focusing on the widely shared polymorphisms in nonstructural (nsp3, nsp4, nsp6, 24 nsp12, nsp13 and nsp14) cistrons, structural (spike and nucleocapsid) and accessory (ORF8) genes. 25Six virus subtypes were predominant in the population, but all sixteen showed amino acid 26 replacements which might have phenotypic implications. We hypothesize that the virus subtypes 27 detected in this study are records of the early stages of the SARS-CoV-2 diversification that were 28 randomly sampled to compose the virus populations around the world, a typical founder effect. The 29 genetic structure determined for the SARS-CoV-2 population provides substantial guidelines for 30 maximizing the effectiveness of trials for testing the candidate vaccines or drugs. Main 32In December 2019, a local pneumonia outbreak of initially unknown etiology was detected in 33 Wuhan (Hubei, China) and quickly determined to be caused by a novel coronavirus 1 , named Severe 34 acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 2 and the disease as COVID-19 3 . SARS- 35CoV-2 is classified in the family Coronaviridae, genus Betacoronavirus, which comprises enveloped, 36 positive stranded RNA viruses of vertebrates 2 . Two-thirds of SARS-CoVs genome is covered by the 37 ORF1ab, that encodes a large polypeptide which is cleaved into 16 nonstructural proteins (NSPs) 38 involved in replication-transcription in vesicles from endoplasmic reticulum (ER)-derived 39 membranes 4,5 . The last third of the virus genome encodes four essential structural proteins: spike (S), 40 envelope (E), membrane (M), nucleocapsid (N) and several accessory proteins that interfere with the 41 host innate immune response 6 . 42Populations of RNA viruses evolve rapidly due to their large population sizes, short generation 43 times, and high mutation rates, this latter being a consequence of the RNA-dependent RNA 44 polymerase (RdRP) which lacks the proofreading activity 7 . In fact, virus populations are composed of 45 a broad spectrum of closely related genetic variants resembling one or more master sequences [8][9][10] . 46 Mutation rates inferred for SARS-CoVs are considered moderate 11,12 due to the independent 47 proofreading activity 13 . However, the large SARS-CoV genomes (from 27 to 31 kb) 14 provide to them 48 the ability to explore the sequence spa...
The white mold (Sclerotinia sclerotiorum) is one of the most destructive cotton disease. Genetic resistance is one of the main strategies to control this disease. Thus, this study aimed to determine an appropriate period of exposition and concentration of oxalic acid to identify levels of physiological resistance to white mold in white fiber cotton genotypes. The study was implemented in two periods (August to October and November to January) in randomized complete block design, in a split-split-plot factorial in time, with five replications, where the plot factor was the concentration of oxalic acid (20; 40 mM) and the sub-plot factor was the 20 cotton genotypes, the sub-sub-plot factor was the time of exposure to oxalic acid (24h; 48h; 72h). The experimental units, or plots, were composed of test tubes with one cotton plant shoot partially immersed in oxalic acid solution. The biomass of the cotton shoots was evaluated at 24, 48, and 72 h. The loss of water caused by the exposure to oxalic acid indirectly indicates the level of cotton resistance to white mold. The results suggest that the most appropriate exposition time and concentration of oxalic acid for cotton evaluation of resistance to white mold were 20 mM at 48 hours, respectively. In these conditions, the cotton genotypes that presented the greatest average fresh mass were: UFU-14 A, UFU-14 B, UFU-14 F, UFU-14 H, and UFU-14 S, which could be used as sources of resistance to white mold in cotton breeding programs
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.